Effects of a SGLT2 Inhibitor in type 2 Diabetes Mellitus
Not Applicable
Recruiting
- Conditions
- type 2 Diabetes Mellitus
- Registration Number
- JPRN-UMIN000017461
- Lead Sponsor
- ephrology, endocrinology and vascular medicine at Tohoku University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
The patient: *has a history of allergy to this drug *has moderate or severer kidney disease with uncontorolled electrolyte imbalance, volume overload, and/or advanced malnutrition *is on renal replacement therapy *has developed type1 DM *has diabetic ketoacidosis or diabetic -/pre comatose *is with severe infectious disease, in perioperative period, or with severe trauma *is under the twenty years of age *is unable to give a written informed concent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood glucose body weight
- Secondary Outcome Measures
Name Time Method renal function uremic toxin